Cite

    Murphy, C. et al. (n.d.). Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer. Oral oncology. 51 (11), pp. 1034-1040. [Online].